We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cello Health Plc | LSE:CLL | London | Ordinary Share | GB00B0310763 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 161.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCLL
RNS Number : 1344M
Cello Group plc
25 April 2018
25 April 2018
Cello Group plc
("Cello" or the "Company")
Change of Name update
Further to the announcement made on 23 April 2018, the Company confirms that it has decided to change its name to "Cello Health plc" instead of "Cello Health Group plc" and it is expected that this change will become effective tomorrow. The Company's ticker symbol "CLL" will remain unchanged.
Once the change of name has become effective, a further announcement will be made and it is expected that the Company's website address will change to www.cellohealthplc.com.
Enquiries:
Cello Group plc
Mark Scott, Chief Executive 020 7812 8460
Mark Bentley, Group Finance Director
Cenkos Securities plc
Mark Connelly 020 7397 8900
Harry Hargreaves
Buchanan
Mark Court
Jamie Hooper 020 7466 5000
Sophie Wills
This information is provided by RNS
The company news service from the London Stock Exchange
END
CANBUGDSCXDBGIU
(END) Dow Jones Newswires
April 25, 2018 11:45 ET (15:45 GMT)
1 Year Cello Health Chart |
1 Month Cello Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions